Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Current Assets (2016 - 2026)

Orthofix Medical has reported Current Assets over the past 17 years, most recently at $461.5 million for Q1 2026.

  • For the quarter ending Q1 2026, Current Assets rose 18.24% year-over-year to $461.5 million, compared with a TTM value of $461.5 million through Mar 2026, up 18.24%, and an annual FY2025 reading of $416.8 million, down 3.79% over the prior year.
  • Current Assets came in at $461.5 million for Q1 2026, up from $416.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $461.5 million in Q1 2026 to a low of $246.9 million in Q3 2022.
  • Median Current Assets over the past 5 years was $394.2 million (2025), compared with a mean of $370.6 million.
  • The sharpest move saw Current Assets decreased 5.12% in 2022, then soared 64.24% in 2023.
  • Over 5 years, Current Assets stood at $256.0 million in 2022, then soared by 64.24% to $420.4 million in 2023, then grew by 3.05% to $433.3 million in 2024, then fell by 3.79% to $416.8 million in 2025, then increased by 10.72% to $461.5 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Current Assets are $461.5 million (Q1 2026), $416.8 million (Q4 2025), and $394.2 million (Q3 2025).